Legacy Bridge’s Biogen BIIB Stock Holding History

Legacy Bridge’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$199K	Hold	880	–	–	0.06%	153
2026 Q2	$190K	Hold	880	–	–	0.06%	157
2026 Q1	$161K	Sell	880 -30	-3%	-$5.53K	0.06%	153
2025 Q4	$160K	Buy	910 +30	+3%	+$4.9K	0.07%	150
2025 Q3	$123K	Hold	880	–	–	0.05%	163
2025 Q2	$111K	Sell	880 -61	-6%	-$7.6K	0.05%	155
2025 Q1	$129K	Buy	941 +1	+0.1%	+$143	0.07%	150
2024 Q4	$144K	Hold	940	–	–	0.07%	150
2024 Q3	$182K	Hold	940	–	–	0.1%	140
2024 Q2	$218K	Hold	940	–	–	0.13%	126
2024 Q1	$203K	Hold	940	–	–	0.12%	134
2023 Q4	$243K	Hold	940	–	–	0.16%	129
2023 Q3	$242K	Sell	940 -3,900	-81%	-$1.04M	0.17%	130
2023 Q2	$1.38M	Sell	4,840 -1,270	-21%	-$378K	0.92%	39
2023 Q1	$1.7M	Hold	6,110	–	–	1.19%	11
2022 Q4	$1.69M	Buy	6,110 +185	+3%	+$52.3K	1.2%	14
2022 Q3	$1.58M	Hold	5,925	–	–	1.26%	11
2022 Q2	$1.21M	Hold	5,925	–	–	0.89%	31
2022 Q1	$1.25M	Buy	+5,925	New	+$1.29M	0.73%	54

Other funds holding BIIB

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Legacy Bridge's BIIB Position: Q3 2026 in Review

Legacy Bridge held its Biogen (BIIB) position steady in Q3 2026 at 880 shares worth $199K. The position accounts for 0.06% of the portfolio, ranked #153.

Legacy Bridge first reported a position in BIIB in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.7M in Q1 2023. 532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Legacy Bridge held 880 shares of Biogen worth $199K as of Q3 2026.
Legacy Bridge left its Biogen share count unchanged in Q3 2026.
Biogen made up 0.06% of Legacy Bridge's portfolio in Q3 2026, its #153 holding.
Legacy Bridge first reported a position in Biogen in Q1 2022 and has held it in 19 quarters since.
Legacy Bridge's Biogen position peaked at $1.7M in Q1 2023.
532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Legacy Bridge's 13F filing for Q3 2026, filed 28 Oct 2026.